Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities 2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting 2020-10-22 19:30
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings 2020-10-21 19:00
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China 2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification 2020-10-21 10:00
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule 2020-10-21 02:14
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment 2020-10-20 19:00
Key patent granted for Isla101 in Brazil 2020-10-20 03:15
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing 2020-10-19 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference 2020-10-16 20:00
analytica 2020 - free entry from the computer 2020-10-16 17:29
Kazia Executes Agreement To Commence GBM Agile Pivotal Study 2020-10-16 07:30
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions 2020-10-15 20:00
Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture 2020-10-15 11:00
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines 2020-10-15 08:59
Innovent Announces the Appointment of Dr. Yong Jun Liu as the President of the Group 2020-10-15 08:00
CUREMARK Honored by Goldman Sachs for Entrepreneurship 2020-10-15 03:22
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020 2020-10-14 20:00
SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan 2020-10-13 21:00
1 237 238 239 240 241 415